Evaluation of CT perfusion as biomarker for chemotherapy response in pancreatic ductal adenocarcinoma.

T.H. Perik,E.J.M. van Geenen,E.J. Smit,Lodewijk A.A. Brosens,Martijn W.J. Stommel,E.C. Gootjes,K. J. H. M. Van Laarhoven,H. Huisman,J J Hermans

Evaluation of CT perfusion as biomarker for chemotherapy response in pancreatic ductal adenocarcinoma.

2021

T.H. Perik
E.J.M. van Geenen
E.J. Smit
Lodewijk A.A. Brosens
Martijn W.J. Stommel
E.C. Gootjes
K. J. H. M. Van Laarhoven
H. Huisman
J J Hermans

Poster: "ECR 2021 / C-14092 / Evaluation of CT perfusion as biomarker for chemotherapy response in pancreatic ductal adenocarcinoma. " by: " T. H. Perik , E. Van Geenen, E. J. Smit, L. A. A. Brosens, M. W. J. Stommel, E. C. Gootjes, K. J. H. M. Van Laarhoven, H. Huisman, J. J. Hermans; Nijmegen/NL"

Keywords:

chemotherapy response
Pathology
pancreatic ductal adenocarcinoma
Biomarker (medicine)
Perfusion scanning
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations